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ABSTRACT 
Two simple sensitive and precise methods A and B were developed for the estimation of teneligliptin in bulk drug as well as in 
pharmaceutical dosage form. Method A is based on the formation of a red colored chromogen by reaction of teneligliptin with 
potassium thiocyanate in presence of ferric chloride, which has an absorption maximum at 554nm.   Method B is based on the 
formation of an orange colored complex by complexation reaction of teneligliptin with 2, 2’- bipyridyl in the presence of ferric 
chloride which has an absorption maximum at 421nm. The proposed methods are statistically validated and found to be useful for 
the routine determination of teneligliptin in tablets. 
Keywords: Teneligliptin, Colorimetry, Tablets, Validation 
 
Article Info: Received 17 May, 2017; Review Completed 10 July, 2017; Accepted 10 July, 2017; Available online 15 July, 2017 
Cite this article as: 
Sunitha PG, Karthikeyan R, Ranjith kumar B, Muniyappan S, Validated colorimetric methods for the 
estimation of Teneligliptin in tablets, Journal of Drug Delivery and Therapeutics. 2017; 7(4):38-40 
DOI: http://dx.doi.org/10.22270/jddt.v7i4.1467  
*Address for Correspondence  
Sunitha PG, Department of Pharmaceutical Chemistry,  College of Pharmacy, Madras Medical College, 
Chennai-600 003, Tamil Nadu, India       E-mail: sunitha.srm@gmail.com  
 
 
INTRODUCTION 
Teneligliptin (TNG) is used to help control blood sugar 
levels in patients affected by type -2 Diabetes
1, 2
. 
Teneligliptin works by inhibiting the activity of an 
enzyme known as DPP-4. This enzyme is responsible for 
degrading ingredients such as GLP-1(Glucagon-like 
peptide 1), which are needed by the body to control 
blood sugar. Blocking the action of DPP-4 leads to 
increase in GLP-1 levels. GLP-1 helps to increase the 
release of insulin, which in turn lower blood glucose 
levels, thereby making this medicine effective in 
controlling type-2 diabetes
3, 4
. 
Chemically it is [(2S, 4S)-4-[4-(3-Methyl-1-phenyl-1H-
pyrazol-5-yl)-1-piperazinyl]-2-pyrrolidinyl]-3-thiazoli-
dinyl methanone hydrobromide .
5
 The available methods 
for analysis of this drug in biological fluids and 
pharmaceutical products are RP-HPLC method
 6, 7
, LC-
MS method
8
 and HPTLC method.
9
 The present work 
deals with the estimation of TNG in tablets by visible 
spectrophotometric methods. In Method A, TNG reacts 
with potassium thiocyanate and ferric chloride to form a 
red chromogen, which absorbs intensively at 554nm. In 
method B, TNG forms an orange coloured complex with 
2, 2’- bipyridyl and ferric chloride which exhibited λmax 
at 421nm. The method is alternative and comparable in 
specificity and accuracy to chromatography methods, 
which although highly specific and accurate, are more 
time consuming, performed in several steps and are 
rather expensive.  
MATERIALS AND METHODS 
Instrumentation: All spectral and absorbance 
measurements were made on UV-Vis Spectrophotometer 
-1900s. 
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Reagents: 
1. Potassium thiocyanate (2% w/v)   
2. Ethanol (95% w/v)  
3. 2, 2’Bipyridyl (0.1% w/v)  
4. Ferric chloride (5% w/v)   
All reagents used were of analytical grade. 
Preparation of standard solution: 
A 1 mg/ml stock solution of TNG was prepared by 
dissolving 100 mg of drug in 100 ml of ethanol. 
Sample preparation: 
Twenty tablets were weighed and powdered. A quantity 
equivalent to 100mgof TNG was weighed accurately, 
transferred to a beaker, dissolved in ethanol, filtered 
through whatmann filter paper No. 1 into a 25 ml 
volumetric flask and made up to volume with ethanol to 
get a concentration of 1mg/ml. 
Assay: 
Method A: 
Appropriate aliquots of TNG were pipetted out into a 
series of 25 ml volumetric flasks. To each flask 2 ml of 
potassium thiocyanate and 2ml ferric chloride reagent 
were added, mixed thoroughly and made up to volume 
with ethanol. The λmax of the red coloured chromogen 
was found to be 554nm (Figure-1).The absorbance of the 
red coloured chromogen was measured at 554 nm 
against the reagent blank. The red chromogen was stable 
for more than 3 hours. The analytical curve was 
constructed by plotting concentration versus absorbance. 
 
Figure 1: λmax of the red chromogen by Method A 
Method B: 
Appropriate aliquots of TNG were pipetted out into a 
series of 25 ml volumetric flasks. To each flask 2ml of 
ferric chloride (5% w/v) and 3 ml of 2,2’bipyridyl (0.1% 
w/v) were added, heated on a boiling water bath for 15 
minutes, cooled and then made up to volume with 
ethanol. The λmax of the orange coloured chromogen was 
found to be 421nm (Figure-2). The absorbance of the 
orange coloured chromogen was measured at 421 nm 
against the reagent blank. The amount of TNG was 
computed from the calibration curve obtained by 
plotting concentration versus absorbance.  
 
Figure 2: λmax of the orange chromogen by Method B 
Sample Analysis: 
Pharmaceutical formulation of TNG was successfully 
analyzed by the proposed methods. Appropriate aliquots 
were subjected to the above methods and the amount of 
the TNG was determined from the calibration curves. 
The results of sample analysis are furnished in   table- 2. 
RESULTS AND DISCUSSION 
The optical characteristics such as absorption maxima, 
Beer’s law limits, Molar absorptivity and Sandell’s 
sensitivity are furnished in table-1. The regression 
characteristics like slope (b), intercept(a), correlation 
coefficient(r), percent relative standard deviation 
(%RSD) and standard error (SE) obtained from different 
concentrations were calculated and the results are 
summarized in table-1. 
To study the accuracy and reproducibility of the 
proposed methods, recovery experiments were carried 
out by adding a known amount of drug to pre-analyzed 
sample and the percentage recovery was calculated. The 
results are furnished in table-2.The results indicate that 
there are no interference of other ingredients present in 
the formulation. Thus, the proposed methods are simple, 
sensitive, precise, accurate and reproducible and useful 
for the routine determination of TNG in bulk drug and 
its pharmaceutical dosage form. 
ACKNOWLEDGEMENTS 
We are thankful to the Department of Pharmaceutical 
Chemistry, Madras Medical College, Chennai-03, for 
providing the instrumentation and laboratory facilities. 
 
    
   
Sunitha et al                                                                                                           Journal of Drug Delivery & Therapeutics. 2017; 7(4):38-40                                
ISSN: 2250-1177                                                                              [40]                                                                            CODEN (USA): JDDTAO 
Table 1: Optical characteristics, Precision and Accuracy of the proposed methods 
Parameter  Method A  Method B  
λmax (nm)  554nm 421nm 
Beer’s law limit(μg/ml)  0.1 - 0.6 0.2 - 1.6  
Molar absorptivity (Lmol-1cm-1)  40.61 x 10
3
 43.03 x10
3
 
Sandell’s sensitivity (μg/cm²/0.001 absorbance unit)  0.01786 0.019916 
Regression equation(*y)  
Slope(b)  0.13714 0.76735 
Intercept(a)  -0.08413 0.003134 
Correlation  co-efficient (r)  0.9999 0.9941 
% RSD  0.144 0.078 
Standard error(SE)  0.0177 0.171 
*y = a+bc where c is the concentration of TNG in μg/ml. 
                 Table 2: Assay and recovery of TNG in the dosage form (tablets) 
Method Labelled amount (mg) Amount obtained (mg)* Percentage recovery** 
A 20.00 19.95 100.01 
B 20.00 20.24 99.99 
*Average of six determinations  ** Average of three determinations 
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